Clinical Trials Directory

Trials / Completed

CompletedNCT00590759

Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms

A Clinical Evaluation of the GORE TAG Thoracic Endoprosthesis in the Primary Treatment of Descending Thoracic Aortic Aneurysms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
W.L.Gore & Associates · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this post-approval study is to evaluate the long-term performance of the GORE TAG® Thoracic Endoprosthesis (TAG device) in the primary treatment of descending thoracic aortic (DTA) aneurysms

Conditions

Interventions

TypeNameDescription
DEVICEGORE TAG® Thoracic Endoprosthesisimplant

Timeline

Start date
2005-08-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2008-01-11
Last updated
2014-08-07
Results posted
2014-08-07

Locations

25 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00590759. Inclusion in this directory is not an endorsement.

Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms (NCT00590759) · Clinical Trials Directory